← Back to news
Y

Yahoo Finance

This High-Conviction Dividend Stock Just Triggered a Rare Buying Opportunity for Passive Income Investors

Y

Price Prediction: Carnival Has 31% Upside as Q2 Earnings Beat Masks Opportunity

Y

After Tepper, Icahn, and Druckenmiller Dumped These 3 Stocks, They Kept Climbing. Time to Sell?

Y

PCE inflation tops 4% in May 2026, but spending stays strong

Y

Elon Musk’s SpaceX has been on a wild ride post-IPO. Should you try to get on?

Y

SpaceX’s Move Into Neocloud Operations Is Raising Expectations for Its Valuation and Partners Like Nvidia and Intel.

Y

Getty Images Stock Doubles After OpenAI Partnership. Far More Upside Could Be Ahead.

Y

Itoham Yonekyu acquires New Zealand meat group Greenlea

Y

Hershey taps PepsiCo executive for US president role

Y

IBM stock seesaws after unveiling chip 'the size of a fingernail' in AI push

Y

IBM stock pops as company unveils chip 'the size of a fingernail' in AI push

Y

Forget SpaceX: Leopold Aschenbrenner’s Situational Awareness Likes This AI Energy Stock You Shouldn’t Miss

Y

Salesforce Stock Is at a 3-Year Low. Should Investors Consider Buying?

Y

JPMorgan names Doug Petno and Troy Rohrbaugh co-presidents

Y

Wedbush says chip rally has further to run after Micron's blowout quarter

Y

Qualcomm, Sandisk, Western Digital, Wendy’s, and More Stocks That Explain Today’s Market

Y

AtaiBeckley to join Russell 2000 and Russell 3000 indexes following annual reconstitution

Y

US cranks up pressure on China EVs with Polestar ban

Y

Supermicro Stock Jumps on Wall Street Upgrade. The Real Test Is Still Ahead.

Y

4 Stocks Powering the AI Revolution Behind the Scenes

Y

Seller concessions vs. seller credit: What's the difference?

Y

Bitcoin and ethereum prices today, Thursday, June 25, 2026: Bitcoin tumbles further below $60,000

Y

Bitcoin and ethereum prices today, Thursday, June 25, 2026: Bitcoin hits its lowest levels in years

Y

Apple raises prices of MacBooks, iPads as memory costs skyrocket

Y

SpaceX (SPCX) Is Down 31% From Its High and Is Now Borrowing $25 Billion. Should Investors Be Worried?

Y

PCE Inflation Data, Falling Oil Prices Calm Fed Fears (Live Coverage)

Y

World stocks climb on chip rally; dollar steadies near one-year high

Y

5 High-Yielding Dividend Kings Retirees and Boomers Can Buy Today and Safely Hold Forever

Y

Prenetics Global Limited (PRE) Receives Bullish Coverage as IM8 Targets Supplement Market Growth

Y

Is Lands’ End, Inc. (LE) Stock Set for Growth After Debt Reduction and Strategic Partnership?

Y

Can Palladyne AI Corp. (PDYN) Benefit From Rising Demand for Advanced Defense Technologies?

Y

Is Perion Network Ltd. (PERI) Positioning Itself as an AI-Powered AdTech Growth Story?

Y

Is Bed Bath & Beyond, Inc. (BBBY) Rebuilding Customer Engagement Through Its Legendary Coupon Hunt?

Y

Is Yext, Inc. (YEXT) Facing Growth Challenges After Mixed Q1 Results and Analyst Downgrade?

Y

Innoviva, Inc. (INVA) Launches Nortiva Bio to Advance Long-Acting Oral Drug Platform

Y

Is Upstream Bio, Inc. (UPB) a Rising Biotech Opportunity After New Analyst Coverage?

Y

Is Rocket Pharmaceuticals, Inc. (RCKT) Poised for Recovery After Key Gene Therapy Program Milestone?

Y

Is Elanco Animal Health Incorporated (ELAN) Positioned for Long-Term Growth With Seven Potential Blockbuster Launches?

Y

Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler

Y

PCE report: Fed's preferred inflation measure hits 3-year high, keeping talk of possible rate hike in play

Y

Fed's preferred inflation measure hits three-year high, keeping talk of possible rate hike in play

Y

Fed's preferred inflation measure hits 3-year high, keeping talk of possible rate hike in play

Y

Is Haleon plc (HLN) Stock Still a Growth Opportunity After Analyst Downgrade?

Y

Key inflation gauge jumps to 3-year high in latest sign of affordability challenges

Y

Is GE HealthCare Technologies Inc. (GEHC) Expanding Its Healthcare Technology Lead Through AI-Powered Imaging Solutions?

Y

May US PCE inflation tops 4%, leaves Fed hike on the table

Y

Is Mirum Pharmaceuticals, Inc. (MIRM) Emerging as a Rare Disease Growth Story After New FOP Data?

Y

UniQure N.V. (QURE) Upgraded to Overweight as Huntington’s Disease Program Advances

Y